Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianjin Fumai
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qianjin Fumai is a traditional Chinese medicine (TCM) granule formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is based on the compatibility principles for treating palpitations found in the classic medical texts *Beiji Qianjin Yaofang* and *Qianjin Yifang* by Sun Simiao. The formulation is primarily investigated for the treatment of ventricular premature complexes (VPC), with clinical research focusing on its ability to reduce the frequency of premature beats and improve electrocardiographic markers such as the Tpeak-end interval. Additionally, the drug is evaluated for its impact on psychological symptoms, such as depression, which often accompany chronic cardiac conditions.
- Brand names
- Qianjin Fumai Granules
- Other names
- Qianjin Fumai Granules
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on Qianjin Fumai.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qianjin Fumai.